Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in ...

Refyne has raised a new financing round, just seven months after securing its previous funding, as the Bengaluru-based startup scales its platform that helps workers access their earned salaries in ...

Hyaluronic acid 20mg/mL, lidocaine 3mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

Fintech platform Refyne on Wednesday said it has raised $82 million in its Series B funding led by Tiger Global. The platform enables employees to withdraw their earned salary in real time before the ...

There's a new filler in town (actually, two new fillers) and they're billed as the next big thing in the fight against laugh lines. Galderma, the pharmaceutical company behind injectables like ...

People are coming on the app almost 10 times a month just to see how much they have earned, says pay-on-demand startup Refyne’s co-founder and CTO Apoorv Kumar, describing how the concept of Earned ...

Bengaluru, July 26 (IANS) Earned wage access platform Refyne on Tuesday said its salary on-demand service is now available on WhatsApp that will help employees access their paychecks in real time. The ...

Galderma launches OBT hyaluronic acid injectables Restylane Defyne and Refyne in Japan: Zug, Switzerland Thursday, February 12, 2026, 13:00 Hrs [IST] Galderma, the pure-play derma ...